Search alternatives:
significant adverse » significant advantage (Expand Search), significant decrease (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
adverse decrease » rivers decreased (Expand Search)
larger decrease » marked decrease (Expand Search)
significant adverse » significant advantage (Expand Search), significant decrease (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
adverse decrease » rivers decreased (Expand Search)
larger decrease » marked decrease (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Study Data.
Published 2025“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
-
11
Study outcomes.
Published 2025“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
-
12
Patient characteristics.
Published 2025“…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
-
13
Scheme of g-λ model with larger values λ.
Published 2024“…The findings suggest that when λ is respectively equal to 4.19, 8.57, 10, and 12.15, the peak particle velocity (PPV) of the transmitted waves is significantly close to the incident wave amplitude. Furthermore, when λ is fixed, the energy transmission coefficient increases with the incident wave amplitude but decreases with the incident wave frequency. …”
-
14
-
15
-
16
-
17
-
18
Number of adverse reaction case reports of finasteride administration at the PT level.
Published 2025Subjects: -
19
-
20
Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events.
Published 2024Subjects: